Statistics
Publications
2
Citations
200
H-Index
2
Active since
2008
Affiliations
Ruikai Du is an author at University Hospitals Cleveland Medical Center specializing in egfr inhibition, molecular oncology, and met inhibitors.
Publications per year
2008–2008
2
2
Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer
Zhe Tang, Ruikai Du, Shan Jiang et al. · British Journal of Cancer · 2008 · 182 citations · Full text
Medicine, Oncology, Pharmacology +15
1–2 of 2